SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-16-675231
Filing Date
2016-08-08
Accepted
2016-08-08 16:44:04
Documents
53
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d85594d10q.htm 10-Q 672266
2 EX-10.1 d85594dex101.htm EX-10.1 1467980
3 EX-31.1 d85594dex311.htm EX-31.1 8466
4 EX-31.2 d85594dex312.htm EX-31.2 8459
5 EX-32.1 d85594dex321.htm EX-32.1 2825
6 EX-32.2 d85594dex322.htm EX-32.2 2811
  Complete submission text file 0001193125-16-675231.txt   4921165

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT agio-20160630.xml EX-101.INS 585790
8 XBRL TAXONOMY EXTENSION SCHEMA agio-20160630.xsd EX-101.SCH 40184
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE agio-20160630_cal.xml EX-101.CAL 44911
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE agio-20160630_def.xml EX-101.DEF 121495
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE agio-20160630_lab.xml EX-101.LAB 336551
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE agio-20160630_pre.xml EX-101.PRE 221299
Mailing Address 38 SIDNEY STREET 2ND FLOOR CAMBRIDGE MA 02139
Business Address 38 SIDNEY STREET 2ND FLOOR CAMBRIDGE MA 02139 617-272-5275
AGIOS PHARMACEUTICALS INC (Filer) CIK: 0001439222 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36014 | Film No.: 161814717
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences